Nationwide survey of anti-tuberculosis drug resistance in Mongolia

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 9, 2011, Pages 1201-1205

  Buyankhishig, B ^a   Naranbat, N ^a   Mitarai, S ^b   Rieder, H L ^c,d  

^a National Center for Communicable Diseases   (Mongolia)

^b Research Institute for Tuberculosis   (Japan)

^c INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

DST; MDR TB; TB

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE REGISTRY; DRUG RESISTANT TUBERCULOSIS; FEMALE; HEALTH CARE SURVEY; HUMAN; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONGOLIA; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MONGOLIA; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 80051698830     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0594     Document Type: Article

References (9)

1. World Health Organization. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Antituberculosis drug resistance in the world. Report no. 4. WHO/ HTM/TB/2008.394:1-120. Geneva, Switzerland: WHO, 2008.
2. World Health Organization. Global tuberculosis control: surveillance, planning, fi nancing. WHO report 2009. WHO/HTM/ TM/2009.411:1-303. Geneva, Switzerland: WHO, 2009.
3. Naranbat N, Nymadawa P, Schopfer K, Rieder H. Seasonality of tuberculosis in an Eastern-Asian country with an extreme continental climate. Eur Respir J 2009; 34: 921-925.
4. Tsogt G, Naranbat N, Buyankhisig B, Batkhuyag B, Fujiki A, Mori T. The nationwide tuberculosis drug resistance survey in Mongolia, 1999. Int J Tuberc Lung Dis 2002; 6: 289-294. (Pubitemid 34263684)
5. World Health Organization, International Union Against Tuberculosis and Lung Disease. Guidelines for surveillance of drug resistance in tuberculosis, 1997. WHO/TB/96.216:1-36. Geneva, Switzerland: WHO, 1997.
6. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 4th ed. WHO/HTM/TB/2009.422:1-83. Geneva, Switzerland: WHO, 2009.
7. Rieder H L, Van Deun A, Kam K M, et al. Priorities for tuberculosis bacteriology services in low-income countries. 2nd ed. Paris, France: International Union Against Tuberculosis and Lung Disease, 2007.
8. Rieder H L. Drug-resistant tuberculosis: issues in epidemiology and challenges for public health [Editorial]. Tubercle Lung Dis 1994; 75: 321-323. (Pubitemid 24336526)
9. Mitchison D A, Nunn A J. Infl uence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133: 423-430. (Pubitemid 16126276)